Pfizer halts trial for twice a day weight loss drug
The reason for its decision was the high rates of adverse events such as nausea, vomiting, and diarrhoea…
US FDA approves Pfizer’s blood cancer therapy
Elrexfio will be sold in the United States at a list price of $7,556 and $13,051 for the…
US FDA approves Pfizer’s hair loss drug
The FDA's decision makes Litfulo the first to be allowed for the treatment of the condition in adolescents
Pfizer and BioNTech seek emergency use authorization for Corona vaccine for kids below 5 years of age
Pfizer and BioNTech have sought emergency use authorization for Covid-19 vaccine for kids below 5 years of age.
Omicron vaccine will be ready by March, says Pfizer CEO
Pfizer CEO announced on Monday that an Omicron vaccine, one that targets the Omicron variant of coronavirus, will…
Pfizer pill Paxlovid becomes 1st US-authorised home COVID treatment
US health regulators on Wednesday authorised the first pill against COVID-19
Efficacy of Pfizer/BioNTech coronavirus vaccine drops to 84pc after 6 months
The efficacy of the Pfizer/BioNTech coronavirus vaccine fell from 96% to 84% after six months, a new preprint…
Vaccine ready for 12+, Pfizer tells centre, seeks fast-track approval
The US-based multinational pharmaceutical company, Pfizer has sought a fast-track approval for its Covid-19 vaccine. It has told…
Pfizer Covid-19 vaccine expanded to US children as young as 12
Covid-19 vaccines finally are headed for more kids as US regulators on Monday expanded use of Pfizer’s shot…